The warped world of marriage advice before feminism | Aeon Essays

The warped world of marriage advice before feminism | Aeon Essays

Advice columns from decades past provide a chilling glimpse into the horrors of marriage counselling before feminism

Source: The warped world of marriage advice before feminism | Aeon Essays

Advertisements
SCA Pharmaceuticals Issues Voluntary Nationwide Recall of Specific Products Due to Potential Contamination:

SCA Pharmaceuticals Issues Voluntary Nationwide Recall of Specific Products Due to Potential Contamination:

For Immediate Release

October 20, 2017

Contact

Consumers

SCA Pharmaceuticals
 877-550-5059

Media

Mr. Vamsi Vasireddy
SCA Pharmaceuticals
 877-550-5059

Announcement

SCA Pharmaceuticals LLC (“SCA Pharmaceuticals”) is voluntarily recalling all/the following lots of the below listed injectable products to the hospital level. The is a potential for the products to contain microbial contamination.

Administration of a drug product, intended to be sterile, that may contain microbial contamination has the potential to result in serious adverse events which may include life-threatening infections. SCA Pharmaceuticals has not received any customer complaints or reports of adverse events related to this issue, but out of an abundance of caution, is voluntarily initiating this recall.

Product Name Product Number Type of Packaging Indication SCA Lot Number Beyond Use Date Quantity Shipped Date(s) Distributed
Succinylcholine Chloride 20 mg/mL 10 mL syringe 70004-0910-
29
Rigid plastic syringe, 10mL Skeletal muscle relaxant 20170726@35 10/24/2017 1248 07/27/2017
– 07/28/2017
Hydromorphone 1 mg/mL in 25 mL 0.9% Sodium Chloride 70004-0303-
17
Rigid plastic syringe, 30mL Analgesic 20170808@52 11/06/2017 128 08/09/2017
Fentanyl 2 mcg/mL + Bupivacaine 0.125% in 250 mL 0.9% Sodium Chloride 70004-0231-
40
Flexible plastic IV bag, 250mL Analgesic 20170814@20 11/12/2017 116 08/16/2017
– 08/25/2017
Hydromorphone 20 mcg/mL + Bupivacaine 0.075% in 50 mL 0.9% Sodium Chloride 70004-0331-
22
Flexible plastic IV bag, 50mL Analgesic 20170816@65 10/30/2017 60 08/18/2017
Morphine 1 mg/mL in 50 mL 0.9% Sodium Chloride 70004-0100-
22
Flexible plastic IV bag, 50mL Analgesic 20170901@25 11/30/2017 238 09/06/2017
– 09/27/2017
Morphine 1 mg/mL in 100 mL 0.9% Sodium Chloride (CADD) 70004-0100-
63
Flexible plastic bag inside
rigid translucent plastic case (CADD), 100mL
Analgesic 20170905@24 12/04/2017 60 09/06/2017
– 09/18/2017
Oxytocin 30 units added to 500 mL Lactated Ringers 70004-0086-
44
Flexible plastic IV bag, 500mL Precipitate Labor 20170912@13 10/22/2017 450 09/13/2017
– 09/14/2017
Phenylephrine 100 mcg/mL 10 mL in 12 mL syringe 70004-0810-
12
Rigid plastic syringe, 12mL Hypotension 20170920@53 12/19/2017 1221 09/22/2017

 

Product Name Product Number Type of Packaging Indication SCA Lot Number Beyond Use Date Quantity Shipped Date(s) Distributed
Fentanyl 2 mcg/mL (as citrate) Ropivacaine HCl 0.1% 70004-0264-
64
Flexible plastic bag inside
rigid translucent plastic case (CADD), 100mL
Analgesic 20170815@26 11/13/2017 20 08/17/2017
Calcium Gluconate 2 g added to 50 mL 0.9% Sodium Chloride 70004-0510-
30
Flexible plastic IV bag, 50mL Hypocalcemia 20170920@20 11/09/2017 76 9/26/2017
Rocuronium 10 mg/mL 5 mL in 6 mL syringe 70004-850-
09
Rigid plastic syringe, 6mL Skeletal muscle relaxant 20171004@4 01/09/2018 487 10/05/2017

These injectable products’ indicated use and package type are identified in the above table. The affected product lots are also included in the table above. The product can be identified by the attached labels. The products associated with this recall were distributed nationwide to hospitals.

SCA Pharmaceuticals is notifying its customers via telephone, email and US mail and is arranging for return/replacement of all recalled products. Customers that have product which is being recalled, as indicated in the list above, should discontinue use immediately and return the product to SCA Pharmaceuticals at the address below.

SCA Pharmaceuticals
8821 Knoedl Court Little Rock, AR 72205

Consumers with questions regarding this recall can contact SCA Pharmaceuticals at 877-550-5059, between the hours of 8:00 am and 5:00 pm (Central Standard Time), Monday thru Friday.

Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

This recall is being conducted with the knowledge of the Food and Drug Administration.

Page Last Updated: 10/20/2017 

Trump pledges at least $430,000 of his own money to help cover aides’ legal costs related to Russia probes:

Trump pledges at least $430,000 of his own money to help cover aides’ legal costs related to Russia probes:

(You know, when Nixon agreed to do this with the Watergate burglars it became a centerpiece of his impeachment)

trumpdevil

President Trump plans to spend at least $430,000 of his personal funds to help cover the mounting legal costs incurred by White House staff and campaign aides related to the ongoing investigations of Russian meddling in last year’s election, a White House official said.

The Washington Post reported last month that the Republican National Committee had spent roughly that amount to pay lawyers representing Trump and his eldest son, Donald Trump Jr., in the multiple investigations.

The White House official said Trump’s pledge is not meant as a reimbursement to the RNC, but that it does not preclude Trump from doing that at a later time or for increasing the amount available for his aides.

The official requested anonymity to discuss the president’s plans, first reported by Axios, because Trump is not prepared to make a formal announcement.

The arrangement drew immediate criticism from Walter Shaub, the former director of the U.S. Office of Government Ethics, who suggested on Twitter that it is rife with potential conflicts.

“A potential witness or target of an investigation (and boss of investigators) paying for legal fees of other potential witnesses or targets?” Shaub wrote.

A potential witness or target of an investigation (and boss of investigators) paying for legal fees of other potential witnesses or targets? https://twitter.com/jonathanvswan/status/921792708620013568 

The White House official said many issues remain to be resolved, including how the money will be accessed and who can request it. The White House’s and campaign aides’ legal costs are expected to balloon well beyond what Trump is putting forward.

Russian meddling — and other related issues — are being investigated by special counsel Robert S. Mueller III as well as House and Senate committees.

The RNC reported last month that it paid $100,000 to Trump’s personal attorney John Dowd and $131,250 to Jay Sekulow, another member of his legal team.

The party is also covering the mounting legal costs for Donald Trump Jr., spending nearly $200,000 on lawyers who helped him prepare for testimony before the Senate Judiciary Committee. Those payments included more than $166,000 to attorney Alan Futerfas.

The RNC is using a pool of money stockpiled for election recounts and other legal matters to pay the costs of Trump and his son.

RNC officials concluded that it is permissible for the party to pay for the president’s legal fees, according to a person familiar with the conversations. Separately, party and administration officials are working to determine whether executive branch staff members could have their legal fees defrayed by the RNC or private legal defense funds.

 October 21 at 3:12 PM

Matea Gold contributed to this story.

Trump stokes hopes of Obamacare repeal — setting up Senate for another failure:

Trump stokes hopes of Obamacare repeal — setting up Senate for another failure:

No thumbs down have flipped to thumbs up.

President Donald Trump is pictured. | AP Photo

The reality is that no matter what the president says at the White House or how often he says it, nothing has changed at the other end of Pennsylvania Avenue. | Alex Brandon/AP Photo

President Donald Trump says the Senate has the votes to repeal Obamacare.

That’s news to the Senate.

“I think that’s aspirational,” said Majority Whip John Cornyn, who counts votes for the GOP.

“If there were 50 votes, we’d be voting,” added John Thune (R-S.D.), another member of Republican leadership.

Repeatedly claiming that Republicans have the votes to repeal major parts of Obamacare early next year, Trump is stoking expectations that the GOP can fulfill its seven-year pledge before the 2018 midterm elections — a promise that Republicans once again might not be able to keep.

The Senate, Trump says, will have the 50 votes needed to enact the bill known as Graham-Cassidy, the last of a series of repeal bids that went down in flames this summer and fall.

The reality is that no matter what the president says at the White House or how often he says it, nothing has changed at the other end of Pennsylvania Avenue.

Not a single “no” vote has flipped to a “yes.” When senators talk about repeal after months of failure, they are talking about hopes and dreams — not about 50 votes to pass it.

“I think eventually, I may be speaking aspirationally, eventually we’ll have 50 votes for Graham-Cassidy or something like that,” Thune said.

The cold hard reality has not stopped Trump — who has never served in a legislature and who confounded senators with his rapid-fire conflicting statements all week about whether he favored a bipartisan Obamacare stabilization effort — from insisting there are 50 votes for dismantling the 2010 health law.

“We are very close,” Trump said Tuesday. “As soon as we’re finished with taxes, we really feel we have the votes to get block grants into the states.”

Of course, when, whether and how Republicans get through tax reform is another story.

The Graham-Cassidy bill would have undone much of Obamacare and given states block grants to figure out health care for themselves — with much less money than they would have under the law today. It’s named for two of its key sponsors, Lindsey Graham (R-S.C.) and Bill Cassidy (R-La).

The president has predicted that in early 2018, Republicans would approve a new budget with a special rule allowing them to pass Obamacare repeal with 50 votes in the Senate instead of the 60 typically needed for legislation. They had that 50-vote threshold through much this year, but they still couldn’t pass repeal. And that budget resolution expired at the end of the fiscal year.

Trump wants to try again.

“I think we have the votes or we’re certainly within one vote, and when you’re within one vote, you’re able to get a vote,” Trump said Thursday, although he acknowledged vote counts are “fragile.

“We’ve found that out. We’ve seen that. I’ve learned that,” he said. “I thought we had it the last time, and somebody came out of the blue and voted against it. So now we start the process all over again. But the block grant, the concept of blocking it out, block grants to the states, that’s what people want.”

The president acknowledged Friday that “people are criticizing me for saying” Republicans have the votes, but he reiterated the pledge again.

“I think we actually have the votes for that,” he said. “You know, we were basically one short.”

While many Republicans still favor repeal, some privately worry that renewing the contentious debate — especially with Trump raising expectations of success — will only lead to another high-profile failure. And failure would come even closer to the midterms, when Republicans need to deliver achievement to their voters.

But the Senate’s biggest proponents of repeal say Trump is right in a sense. Among 52 Senate Republicans, there are 50 votes for the idea of repeal. They’ve just stumbled on the process.

Graham remains optimistic. “We’re at 48 — we need two more, and we may actually get more than two,” he said.

Graham still maintains he could have passed his bill if he had more time, if the budget rule had not expired. “The question is: If you started over and used a regular order process, can you get to 50? And I believe we can,” he said. “I believe the product is getting better and better in the eyes of the Senate.”

There are many hurdles — including the fact that the Congressional Budget Office hasn’t finished a full score of the Graham-Cassidy bill. Every CBO score of the other repeal bills forecast that millions of people would lose insurance — one reason they all collapsed.

The House managed to narrowly pass a separate Obamacare repeal bill last spring after months of false starts. It was a tough vote for many House members, who are still miffed that the Senate left them hung out to dry.

What it really boils down to, though, is that no senator is ready to flip a thumbs down to thumbs up.

“We need to fix it,” John McCain (R-Ariz.) said of the Obamacare markets. “And the fix, I think, is larger than Cassidy-Graham. It’s much larger than that.”

But McCain says if Republicans are able to pass a bill to try to stabilize the Obamacare markets — which was introduced this week by Lamar Alexander (R-Tenn.) and Patty Murray (D-Wash.) — it could provide some momentum for repeal.

“To get something done usually makes it easier for something else to get done,” he said.

The GOP’s only glimmer of hope is that Lisa Murkowski (R-Alaska), who voted “no” on repeal over the summer, is open to the idea of Graham-Cassidy. But it’s not accurate to say she’s locked in to be the deciding 50th vote.

“I don’t know what the vote count is on Graham-Cassidy,” Murkowski said. “I think in fairness, because we didn’t see that [roll call vote] materialize, to suggest that there is a hard number — maybe it’s wishful thinking, maybe it’s speculation, but I think it remains to be seen.”

Murkowski likes the idea of block grants to states, but insists that Alaska can’t be pushed into a one-size-fits-all solution or endure a huge cut in funding.

But she didn’t say “never” either.

“Trying to fit us into a system that is a better fit for the lower 48 might not work for us, so give us more flexibility here, and that was the beauty behind the Graham-Cassidy concept,” she said.

 

US preparing for North Korea’s ‘final step’:

US preparing for North Korea’s ‘final step’:

Washington (CNN)CIA Director Mike Pompeo said the United States has to act as if North Korea is on the verge of being able to strike it with a missile and act accordingly — and that President Donald Trump is ready to do so.

“From a US policy perspective, we ought to behave as if we are on the cusp of them achieving that objective,” Pompeo said Thursday at a security forum held by the Foundation for Defense of Democracies. “They are so far along in that, it’s now a matter of thinking about how do you stop the final step.”
“Whether it happens on Tuesday or a month from Tuesday, we’re in a time where the President has concluded that we have a global effort to ensure that [North Korean leader] Kim Jong Un does not obtain that capacity,” Pompeo continued.
Pompeo is among a number of former officials who have been signaling the increased possibility of a slide into military confrontation with North Korea over its refusal to back down from its nuclear program.
The CIA chief spoke at the forum shortly before national security adviser H.R. McMaster, who also said the President wasn’t prepared to accept a nuclear Pyongyang.
 

The Trump administration comments came a day after former CIA Director John Brennan put the chances of military conflict with North Korea as high as 20% to 25%.
The isolated Asian nation conducted its sixth and most powerful nuclear test in September, claiming it had detonated a miniaturized hydrogen bomb that could be mounted on a missile. It’s also been steadily working on its missile capabilities, firing 22 missiles during 15 tests from February to mid-September.
Even as other countries have urged caution, dialogue and reciprocal confidence-building measures, Trump has belittled the North Korean leader as “rocket man,” dismissed Secretary of State Rex Tillerson’s efforts to broker a diplomatic solution, and hinted that he is ready to take military action.
Asked at Thursday’s event about the threat posed by North Korea, McMaster said that Trump will not accept a nuclear North Korea that threatens the US, putting the administration in a “race” to resolve the increasingly tense standoff before it devolves into a military confrontation.
“He’s not going to accept this regime threatening the United States with nuclear weapons,” McMaster said. “There are those who would say, well, why not accept and deter. Well, accept and deter is unacceptable.”
“So this puts us in a situation where we are in a race to resolve this short of military action,” McMaster said. “Everybody knows it. We all know it. … Our allies and partners know it. China knows it. Russia knows it.”
Brennan, speaking Wednesday night at Fordham University School of Law, stressed that, “there really is no good military solution to this issue.”

“A 1 in 4, 1 in 5 chance”

“The prospects for military conflict on the Korean Peninsula are greater than they have been in several decades,” he said. “I don’t think it’s likely or probable, but if it’s a one in four, one in five chance, that’s too high.” Asked if that’s the rating he’d give for the chances of conflict, he said, “Yeah, I guess I would.”
Brennan sketched out a scenario in which, “some kind of limited military engagement that would result in some deaths, that could then quickly trigger some retaliatory strikes that could escalate.” On top of that “conventional scenario of escalation,” he reminded the crowd that North Korea has finely honed cyber capabilities.
“So I think we have to be mindful here that there are a number of scenarios here that could lead to an escalation that we really need to be trying to avoid,” Brennan said. Trump isn’t helping on that score, he said.
“You have two leaders of the two major protagonist countries that are hurling these broadsides back and forth, and they have a lot of personal political face involved in it,” he said.
“I don’t agree that the tack that Mr. Trump has taken is a constructive and productive one,” Brennan said, calling the references to “Rocket Man” and other insults “irresponsible.”
McMaster praised Trump’s handling of the crisis, saying that the President’s leadership had created the possibility of an “unprecedented level of international cooperation on the issue.”
He also praised Tillerson’s efforts to increase international pressure on North Korea, which has moved some countries to cut diplomatic relations with Pyongyang, expel its ambassadors and in some cases, ban North Korean guest workers. North Korea, meanwhile, has said it won’t be willing to talk to the US until it ensures it has missile and nuclear capabilities.

Updated 6:30 PM ET, Fri October 20, 2017